Given the timing of the first and second interim results, the trial endpoint should be reached in Q4. At that point it's up to the IDC to compile the data and make their findings available to MRK/ARIA but I do think year end is in the ballpark.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.